Drug Markets/Epinephrine

Epinephrine

18 NDCs across 8 manufacturers|10 Generic,8 Brand

Epinephrine is used to treat airway obstruction, anaphylaxis, bradycardia, bronchial spasm, open-angle glaucoma and heart arrest, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved May 23, 1984. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $120 million on Epinephrine across 583,000 claims for 463,000 beneficiaries.

Epinephrine is available as 18 NDCs from 8 manufacturers (10 generic, 8 brand), with NADAC prices from $112.84 to $359.59 per EA — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Active FDA drug shortage

22 Epinephrine presentations are currently listed in FDA's drug shortage database (first posted Feb 22, 2012). Shortages can move NADAC prices in the following weeks.

Total NDCs

18

10G / 8B

Manufacturers

8

competing in market

Price Spread

$112.84 – $359.59

per EA, 15 of 18 NDCs

7d Activity

27↑3↓-15 flat

avg +0.7% WoW · of 18 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

18 NDCs total, 18 shown

WatchDrug ↕Price 7d Change ↕
NEFFY 2 MG/0.1 ML NASAL SPRAY
$359.5922
per EA
+0.01%
NEFFY 1 MG/0.1 ML NASAL SPRAY
$359.4378
per EA
+0.05%
AUVI-Q 0.1 MG AUTO-INJECTOR
$308.9738
per EA
—
AUVI-Q 0.3 MG AUTO-INJECTOR
$308.4180
per EA
—
AUVI-Q 0.15 MG AUTO-INJECTOR
$307.6647
per EA
—
EPIPEN JR 2-PAK 0.15 MG INJCTR
$290.6380
per EA
—
EPIPEN 2-PAK 0.3 MG AUTO-INJCT
$289.9600
per EA
—
EPINEPHRINE 0.15 MG AUTO-INJCT
$142.1545
per EA
-0.13%
EPINEPHRINE 0.3 MG AUTO-INJECT
$141.7961
per EA
0.00%
EPINEPHRINE 0.3 MG AUTO-INJECT
$134.7457
per EA
+0.29%
EPINEPHRINE 0.15 MG AUTO-INJCT
$130.8274
per EA
+0.36%
EPINEPHRINE 0.15 MG AUTO-INJCT
$121.2856
per EA
+1.63%
EPINEPHRINE 0.15 MG AUTO-INJCT
$121.2856
per EA
+1.63%
EPINEPHRINE 0.3 MG AUTO-INJECT
$112.8434
per EA
+0.42%
EPINEPHRINE 0.3 MG AUTO-INJECT
$112.8434
per EA
+0.42%
ADRENALIN 1 MG/ML VIAL
$7.7955
per ML
—
EPINEPHRINE 1 MG/10 ML LUERJET
$1.3119
per ML
+2.75%
EPINEPHRINE 1 MG/10 ML ABBOJCT
$1.1940
per ML
—

Frequently Asked Questions

What is Epinephrine used to treat?

Epinephrine is used to treat airway obstruction, anaphylaxis, bradycardia, bronchial spasm, open-angle glaucoma and heart arrest, per the National Library of Medicine's MED-RT classification.

When did Epinephrine become available as a generic?

FDA approved the first generic Epinephrine (ANDA) on May 23, 1984. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Epinephrine?

In 2024, Medicare Part D spent $120 million on Epinephrine across 583,000 claims for 463,000 beneficiaries.

Is Epinephrine in shortage?

Yes — FDA's drug shortage database currently lists 22 Epinephrine presentations with status "Current", first posted Feb 22, 2012.

How many Epinephrine products are on the market?

The Epinephrine drug market contains 18 NDCs from 8 manufacturers — 10 generic and 8 brand products.

What is the price range for Epinephrine?

NADAC reference prices for Epinephrine range from $112.8434 to $359.5922 per EA — the most expensive product costs about 3.2× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Epinephrine cheaper than brand?

The average generic NADAC for Epinephrine is $127.2227 per EA, versus $317.8121 for brand-labeled products — brand versions average about 2.5× the generic price.

Which manufacturers make Epinephrine?

8 manufacturers list Epinephrine in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (4), Amneal Pharmaceuticals of New York LLC (4), kaleo, Inc (3), ARS Pharmaceuticals Operations, Inc. (2), Teva Pharmaceuticals USA Inc. (2).

How has the price of Epinephrine changed recently?

Over the past 7 days, 27 Epinephrine NDCs rose and 3 fell, with a market-wide average change of +0.7%.